← Leaderboards
Ram Murty
Murty Pharmaceuticals, Inc.
$2,602,634
Attributed
$2,602,634
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $857K · FY2013–20$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,602,634 · 2
By mechanism
N01$2,602,634 · 2
Top collaborators
No co-investigators on record.
Most similar at Murty Pharmaceuticals, Inc.
Same institution · by research overlap
- Ram B Murty$986,020
Others in their field
Top investigators on “National Institute Of Drug Abuse”
- Barbara Driver · Westat, Inc.$95,724,261
- Jeffrey H Samet · Boston University Medical Campus$90,210,613
- T John Winhusen · University Of Cincinnati$75,983,072
- Paul Vanveldhuisen · The Emmes Company, Llc$63,018,753
- Lloyd D Johnston · University Of Michigan At Ann Arbor$60,310,192
- Robert Lindblad · The Emmes Company, Llc$49,324,035
Research focus
National Institute Of Drug AbusePharmacologic SubstancePharmaceutical PreparationsValidationPre-ClinicalProgram DevelopmentDocumentationPlacebosDosage FormsContractorResourcesAnalytical MethodClinical TrialsContractsData ReportingEvaluationGenerationsMaintenanceMethod DevelopmentPreparationAddictionSiteSubstance Abuse TreatmentFormulation
Grant awards (9)
DEVELOPMENT&MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/1$97,575
N01 · FY2020 · DA · contact PI
DEVELOPMENT & MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$93,608
N01 · FY2019 · DA · contact PI
IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$308,187
N01 · FY2018 · DA · contact PI
IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorcer. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$697,612
N01 · FY2017 · DA · contact PI
IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorcer. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.$155,703
N01 · FY2016 · DA · contact PI
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$6,500
N01 · FY2016 · DA · contact PI
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$856,983
N01 · FY2015 · DA · contact PI
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$286,466
N01 · FY2014 · DA · contact PI
OTHER FUNCTIONS: Development and Manufacture of Pharmaceutical Products for Addic$100,000
N01 · FY2013 · DA · contact PI